MicroRNA profile: A promising ancillary tool for accurate renal cell tumour diagnosis

British Journal of Cancer

Volumn 109, Issue 10, 2013, Pages 2646-2653

  Silva Santos, R M ^a   Costa Pinheiro, P ^a   Luis, A ^a   Antunes, L ^a   Lobo, F ^a   Oliveira, J ^a   Henrique, R ^a,b   Jeronimo C ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 141; MICRORNA 155; MICRORNA 183; MICRORNA 200B; MICRORNA 21; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CHROMOPHOBE ADENOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84887836420     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.552     Document Type: Article

References (34)

1. Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumacher B, Tickoo SK (2004) Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 45(6): 593-602.
2. Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26(3): 281-291.
3. Baldewijns MM, van Vlodrop IJ, Schouten LJ, Soetekouw PM, de Bruine AP, van Engeland M (2008) Genetics and epigenetics of renal cell cancer. Biochim Biophys Acta 1785(2): 133-155.
4. Biosystems A (2004) Guide to Performing Relative Quantitation of Gene Expression Using Real-Time Quantitative PCR: Applied Biosystems.
5. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W (2011) Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PloS One 6(3): e17745.
6. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM (2010) Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43(1-2): 150-158.
7. Costa VL, Henrique R, Ribeiro FR, Pinto M, Oliveira J, Lobo F, Teixeira MR, Jeronimo C (2007) Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer 7: 133.
8. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours. IARC: Lyon. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12(12): 861-874.
9. Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, Bjarnason G, Sugar L, Attalah MI, Yousef GM (2012) The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn 14(4): 385-392.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12): 2893-2917.
11. Ficarra V, Martignoni G, Galfano A, Novara G, Gobbo S, Brunelli M, Pea M, Zattoni F, Artibani W (2006) Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol 50(4): 786-793.
12. Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, Spector Y (2010) Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12(5): 687-696.
13. Henrique R, Luis AS, Jeronimo C (2012) The epigenetics of renal cell tumors: from biology to biomarkers. Front Genet 3: 94.
14. Jeronimo C, Henrique R (2011) Epigenetic biomarkers in urological tumors: A systematic review. Cancer Lett; e-pub ahead of print 23 December 2011; doi:10.1016/j.canlet.2011.12.026.
15. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75(4): 835-841.
16. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, Nietfeld W, Rudel T, Jung K, Kristiansen G (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13(9B): 3918-3928.
17. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B (1997) The Heidelberg classification of renal cell tumours. J Pathol 183(2): 131-133.
18. Lee HW, Lee EH, Lee CH, Chang HK, Rha SH (2011) Diagnostic utility of caveolin-1 and MOC-31 in distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Korean J Urol 52(2): 96-103.
19. Lin F, Yang W, Betten M, Teh BT, Yang XJ (2006) Expression of S-100 protein in renal cell neoplasms. Hum Pathol 37(4): 462-470.
20. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043): 834-838.
21. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200 c. J Pathol 216(4): 418-427.
22. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM (2010) The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 8: 64.
23. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT (2009) MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35(1): 109-114.
24. Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O (2012) Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Trans Med 10: 55.
25. Shen SS, Truong LD, Scarpelli M, Lopez-Beltran A (2012) Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Ach Pathol Lab Med 136(4): 410-417.
26. Skinnider BF, Jones EC (1999) Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol 111(6): 796-803.
27. Song CG, Wu XY, Fu FM, Han ZH, Wang C, Shao ZM (2012) [Correlation of miR-155 on formalin-fixed paraffin embedded tissues with invasiveness and prognosis of breast cancer]. Zhonghua Wai Ke Za Zhi 50(11): 1011-1014.
28. Valera VA, Walter BA, Linehan WM, Merino MJ (2011) Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma. J Cancer 2: 515-526.
29. White NM, Yousef GM (2010) MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. BMC Med 8: 65.
30. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3): 189-198.
31. Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y, Du J (2013) High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 49(3): 604-615.
32. Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM (2011) Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 59(5): 721-730.
33. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R (2012) Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One 7(2): e31060.
34. Zhao A, Li G, Peoc'h M, Genin C, Gigante M (2013) Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol 94(1): 115-120.